Table 1.
Demographics, clinical manifestations, laboratory data and outcomes of 58 patients with mycotic aneurysm
| Variables | Mycotic aneurysm without infective spondylitis, N = 52 (%) | Mycotic aneurysm with infective spondylitis, N = 6 (%) | P level |
|---|---|---|---|
| Age (mean ± SD, year) | 70.7 ± 10.2 | 67.0 ± 6.2 | 0.81 |
| Male | 46 (88.9) | 5 (83.3) | 0.55 |
| Clinical features | |||
| Fever | 35 (66.7) | 5 (83.3) | 0.65 |
| Localized back pain | 38 (72.2) | 6 (100) | 0.32 |
| Heart failure | 8 (15.4) | 1 (16.7) | 1 |
| Pulsatile mass | 10 (19.2) | 2 (33.3) | 0.59 |
| Neurological deficit | 0 | 3 (50) | <0.001 |
| Underlying conditions | |||
| Renal disease | 17 (33.3) | 1 (16.7) | 0.65 |
| Immunosuppressive agent user | 17 (33.3) | 1 (16.7) | 0.65 |
| Hypertension | 11 (21.2) | 2 (33.3) | 0.61 |
| Diabetes mellitus | 19 (36.5) | 2 (33.3) | 1 |
| Heart disease | 8 (15.4) | 2(33.3) | 0.27 |
| Laboratory data | |||
| Leukocyte count (mm−3) | 9,694 ± 3,426 | 14,833 ± 9,559 | 0.17 |
| Erythrocyte sedimentation rate (mm/h) | 84.8 ± 23.2 | 86.1 ± 24.3 | 0.45 |
| Blood culture (positive) | 40 (76.9) | 6 (100) | 0.33 |
| Surgical intervention | 31 (59.6) | 4 (66.7) | 1 |
| Mortality (in hospital) | 16 (30.8) | 2 (33.3) | 1 |